Richardson Financial Services’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$542 – 629
2026
Q2
$542 Sell
1
-1
-50% -$563 ﹤0.01% 586
2026
Q1
$1.19K Buy
+2
New +$996 ﹤0.01% 551
2025
Q3
– Sell
-33
Closed -$9.6K – 590
2025
Q2
$9.6K Sell
33
-3
-8% -$897 0.01% 411
2025
Q1
$11.1K Sell
36
-37
-51% -$12.7K 0.01% 373
2024
Q4
$26.1K Sell
73
-2
-3% -$735 0.02% 312
2024
Q3
$23.9K Hold
75
– – 0.02% 323
2024
Q2
$23.9K Buy
75
+11
+17% +$2.91K 0.02% 306
2024
Q1
$14.7K Sell
64
-3
-4% -$677 0.01% 370
2023
Q4
$14.7K Buy
+67
New +$15.4K 0.01% 288

Other funds holding UTHR

Richardson Financial Services's UTHR Position: Q3 2026 in Review

Richardson Financial Services sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 1 share — an estimated $542 sold.

Richardson Financial Services first reported a position in UTHR in Q4 2023 and held it in 9 quarters. The position peaked at $26.1K in Q4 2024. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Richardson Financial Services reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Richardson Financial Services sold 1 United Therapeutics share in Q3 2026, an estimated $542.
  • Richardson Financial Services first reported a position in United Therapeutics in Q4 2023 and held it in 9 quarters.
  • Richardson Financial Services's United Therapeutics position peaked at $26.1K in Q4 2024.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Richardson Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.